Glucagon-Like Peptide-1 Drugs

Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.

UPI · 17h

Medicaid covers GLP-1 weight-loss drugs in just 13 states

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

Yahoo · 13h

A new weight loss drug could beat Ozempic's side effect problem

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose pounds with fewer side effects than current anti-obesity medications on the market.

U.S. News & World Report · 20h

Medicaid Covers GLP-1 Meds for Obesity in Just 13 States

Expanding Medicaid coverage of these drugs could increase access for the almost 40% of adults and 26% of children with obesity in Medicaid,” wrote the research team led by se

Axios Vitals on MSN · 22h

States slow to cover GLP-1s for weight loss

Axios Visuals Budget pressures have kept all but 13 states from covering GLP-1 drugs for weight loss through their Medicaid programs, a new report from KFF shows. Why it matters: The restrictive policies add to equity concerns around the blockbuster drugs,

Hosted on MSN10h

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes medication has become not only a household name but ...

Medscape9h

FDA Updates GLP-1 Label with Pulmonary Aspiration Warning

On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during ...

Glucagon-like peptide-1 receptor agonists tied to lower risk for early-onset colorectal cancer

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer ...

Crain's Cleveland Business2d

Employee benefits & GLP-1: What you need to know

Glucagon-like peptide medications that treat Type 2 diabetes and weight management continue to grow in popularity, though ...

11d

Ars Live: What else can GLP-1 drugs do? Join us today for a discussion.

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

Too Old to Operate7d

Glucagon-like peptide-1 receptor agonists may impact outcomes of endoscopy

The use of glucagon-like peptide 1 (GLP-1) receptor agonists in adults with type 2 diabetes mellitus (T2DM) was not ...

AOL1d

4 Ways to Prevent Muscle Loss on Ozempic & Other Weight Loss GLP-1 Medications

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor ...

22hon MSN

Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs

At the heart of these medications are two key hormones, depending on the drug: GLP-1 (glucagon-like peptide-1) and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results